Gadolinium-based Contrast Agent [EPC] - N0000183362

Pharmacologic Class Information

Pharmacologic Code N0000183362
Pharmacologic Name Gadolinium-based Contrast Agent
Pharmacologic Uses
  • gadolinium-based contrast agent
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Gadolinium-based Contrast Agent

The table contains 23 products whose active ingredient are classified under the same pharmacologic class Gadolinium-based Contrast Agent [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0270-5164Multihance Non-Proprietary Name: Gadobenate DimeglumineInjection, SolutionIntravenousBracco Diagnostics IncACTIVE
0270-5264Multihance Non-Proprietary Name: Gadobenate DimeglumineInjection, SolutionIntravenousBracco Diagnostics IncACTIVE
0407-2943Clariscan Non-Proprietary Name: Gadoterate MeglumineInjection, SolutionIntravenousGe HealthcareACTIVE
50419-320Eovist Non-Proprietary Name: Gadoxetate DisodiumInjection, SolutionIntravenousBayer Healthcare Pharmaceuticals Inc.ACTIVE
50419-325Gadavist Non-Proprietary Name: GadobutrolInjectionIntravenousBayer Healthcare Pharmaceuticals Inc.ACTIVE
65219-080Gadoterate Meglumine Non-Proprietary Name: Gadoterate MeglumineInjectionIntravenousFresenius Kabi Usa, LlcACTIVE
65219-082Gadoterate Meglumine Non-Proprietary Name: Gadoterate MeglumineInjectionIntravenousFresenius Kabi Usa, LlcACTIVE
65219-084Gadoterate Meglumine Non-Proprietary Name: Gadoterate MeglumineInjectionIntravenousFresenius Kabi Usa, LlcACTIVE
65219-086Gadoterate Meglumine Non-Proprietary Name: Gadoterate MeglumineInjectionIntravenousFresenius Kabi Usa, LlcACTIVE
65219-088Gadoterate Meglumine Non-Proprietary Name: Gadoterate MeglumineInjectionIntravenousFresenius Kabi Usa, LlcACTIVE
65219-281Gadobutrol Non-Proprietary Name: GadobutrolInjectionIntravenousFresenius Kabi Usa, LlcACTIVE
65219-287Gadobutrol Non-Proprietary Name: GadobutrolInjectionIntravenousFresenius Kabi Usa, LlcACTIVE
65219-289Gadobutrol Non-Proprietary Name: GadobutrolInjectionIntravenousFresenius Kabi Usa, LlcACTIVE
67684-2000Dotarem Non-Proprietary Name: Gadoterate MeglumineInjectionIntravenousGuerbet LlcACTIVE
67684-2001Dotarem Non-Proprietary Name: Gadoterate MeglumineInjectionIntravenousGuerbet LlcACTIVE
67684-3001Dotarem Non-Proprietary Name: Gadoterate MeglumineInjectionIntravenousGuerbet LlcACTIVE
70436-212Gadobutrol Non-Proprietary Name: GadobutrolInjectionIntravenousSlate Run Pharmaceuticals, LlcACTIVE
70436-214Gadobutrol Non-Proprietary Name: GadobutrolInjectionIntravenousSlate Run Pharmaceuticals, LlcACTIVE